2BBBullish & Bearish
Apellis Pharmaceuticals, Inc. (APLS) trades on NASDAQ. It operates in the Healthcare sector, Biotechnology industry. Its current 2BB score is 0 out of 100.
Apellis Pharmaceuticals, Inc.’s current 2BB score is 0 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 0 | Strongly Weakening |
| Financial strength | 0 | Very Weak |
| Quality | 0 | Very Weak |
| Risk | 0 | Very Low |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-07-29 | — | -0.3434 | — | $211.26M |
| 2026-04-30 | — | -0.3554 | — | $209.29M |
| 2026-02-24 | -0.47 | -0.3884 | $199.91M | $203.70M |